Spain· ES:196006009
NOVOSEVEN 2 mg (100 KUI) POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
A medicinal product containing eptacog alfa, registered in Spain by Novo Nordisk A/S.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- eptacog alfa
- Manufacturer
- Novo Nordisk A/S
- Country
- Spain (ES)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eptacog alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCevenfacta 2mg (90,000units) powder and solvent for solution for injection vialsLFB Biopharmaceuticals Ltd
- BelgiumCevenfacta 2 mgLaboratoire français du Fractionnement et des Biotechnologies
- SwedenCEVENFACTA 2 mg Pulver och vätska till injektionsvätska, lösningLaboratoire français du Fractionnement et des Biotechnologies
- NorwayNovoSevenNovo Nordisk A/S
- IrelandCEVENFACTA 1 mg (45 KIU) powder and solvent for solution for injectionLaboratoire francais du Fractionnement et des Biotechnolgies
- CzechiaCEVENFACTALaboratoire Français du Fractionnement et des Biotechnologies, Puteaux
- FinlandNovosevenNovo Nordisk A/S
- SwitzerlandNovoSeven 1 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cevenfacta, Novoseven
- Liechtenstein · Cevenfacta
- Norway · Cevenfacta, Novoseven
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bef2d74e-3cf9-4fc0-941b-6f5164c88953 GET /v1/drugs/bef2d74e-3cf9-4fc0-941b-6f5164c88953?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1357254000000}",
"nregistro": "196006009",
"substance": "eptacog alfa"
}See everything about eptacog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.